Cargando…
Estimation after blinded sample size reassessment
Blinded sample size reassessment is a popular means to control the power in clinical trials if no reliable information on nuisance parameters is available in the planning phase. We investigate how sample size reassessment based on blinded interim data affects the properties of point estimates and co...
Autores principales: | Posch, Martin, Klinglmueller, Florian, König, Franz, Miller, Frank |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047306/ https://www.ncbi.nlm.nih.gov/pubmed/27697838 http://dx.doi.org/10.1177/0962280216670424 |
Ejemplares similares
-
Sample Size Reassessment and Hypothesis Testing in Adaptive Survival Trials
por: Magirr, Dominic, et al.
Publicado: (2016) -
Maximum type I error rate inflation from sample size reassessment when investigators are blind to treatment labels
por: Żebrowska, Magdalena, et al.
Publicado: (2015) -
Adaptive graph-based multiple testing procedures
por: Klinglmueller, Florian, et al.
Publicado: (2014) -
Graphical approaches for multiple comparison procedures using weighted Bonferroni, Simes, or parametric tests
por: Bretz, Frank, et al.
Publicado: (2011) -
Simultaneous confidence intervals that are compatible with closed testing in adaptive designs
por: MAGIRR, D., et al.
Publicado: (2013)